Spc2 modulates substrate- and cleavage site-selection in the yeast signal peptidase complex
Journal of Cell Biology · 2024
DOI: 10.1083/jcb.202211035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2024. Verfasst von Yeonji Chung und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences and Institute of Biodiversity, Seoul National University , Seoul, South Korea. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins, Membrane Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grand équipement national de calcul intensif, Burroughs Wellcome Fund, National Research Foundation of Korea.
Abstract (Originalsprache)
Secretory proteins are critically dependent on the correct processing of their signal sequence by the signal peptidase complex (SPC). This step, which is essential for the proper folding and localization of proteins in eukaryotic cells, is still not fully understood. In eukaryotes, the SPC comprises four evolutionarily conserved membrane subunits (Spc1–3 and Sec11). Here, we investigated the role of Spc2, examining SPC cleavage efficiency on various models and natural signal sequences in yeast cells depleted of or with mutations in Spc2. Our data show that discrimination between substrates and identification of the cleavage site by SPC is compromised when Spc2 is absent or mutated. Molecular dynamics simulation of the yeast SPC AlphaFold2-Multimer model indicates that membrane thinning at the center of SPC is reduced without Spc2, suggesting a molecular explanation for the altered substrate recognition properties of SPC lacking Spc2. These results provide new insights into the molecular mechanisms by which SPC governs protein biogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences and Institute of Biodiversity, Seoul National University , Seoul, South Korea.
- Laboratoire de Biologie et Modélisation de la Cellule, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France.
- Centre Blaise Pascal de Simulation et de Modélisation Numérique, Ecole Normale Supérieure de Lyon , Lyon, France.
- Molecular Microbiology and Structural Biochemistry, CNRS UMR 5086 and Université Claude Bernard Lyon 1 , Lyon, France.
- Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.
- Structural Biochemistry, Bijvoet Centre for Biomolecular Research, Utrecht University , Utrecht, Netherlands.
ORCID-Profile: Yeonji Chung, Chewon Yim, Gilberto P Pereira, Sungjoon Son, Lisbeth R Kjølbye, Lauren E Mazurkiewicz, Amy M Weeks, Friedrich Förster, Gunnar von Heijne, Paulo C T Souza, Hyun Kim
Förderung
- Grand équipement national de calcul intensif
- Burroughs Wellcome Fund
- National Research Foundation of Korea
- NIGMS NIH HHS
- Swedish Research Council
- University of Wisconsin
- Knut and Alice Wallenberg Foundation
- NIH HHS
Zitieren
APA
Chung, Y., Yim, C., Pereira, G. P., Son, S., Kjølbye, L. R., Mazurkiewicz, L. E., Weeks, A. M., Förster, F., von Heijne, G., Souza, P. C. T., & Kim, H. (2024). Spc2 modulates substrate- and cleavage site-selection in the yeast signal peptidase complex. Journal of Cell Biology. https://doi.org/10.1083/jcb.202211035
Vancouver
Chung Y, Yim C, Pereira GP, Son S, Kjølbye LR, Mazurkiewicz LE, et al. Spc2 modulates substrate- and cleavage site-selection in the yeast signal peptidase complex. Journal of Cell Biology. 2024. doi:10.1083/jcb.202211035
BibTeX
@article{Chung2024,
author = {Chung, Yeonji and Yim, Chewon and Pereira, Gilberto P and Son, Sungjoon and Kjølbye, Lisbeth R and Mazurkiewicz, Lauren E and Weeks, Amy M and Förster, Friedrich and von Heijne, Gunnar and Souza, Paulo C T and Kim, Hyun},
title = {Spc2 modulates substrate- and cleavage site-selection in the yeast signal peptidase complex},
journal = {Journal of Cell Biology},
year = {2024},
doi = {10.1083/jcb.202211035}
}
EUVIMED